Skip to main content
SpringerLink
Log in

Ruxolitinib

Erythematous skin lesions and necrotic centres on lower extremities: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Dasanu CA. Erythematous skin lesions with necrotic centers on lower extremities due to the use of ruxolitinib for primary myelofibrosis. Journal of Oncology Pharmacy Practice 25: 990-992, No. 4, Jun 2019. Available from: URL: http://doi.org/10.1177/1078155218768875 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruxolitinib. Reactions Weekly 1753, 305 (2019). https://doi.org/10.1007/s40278-019-62197-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-62197-z

Search

Navigation